DEFB1 and tuberculosis: Comparing the MIC values from other antimycobacterial peptides with similar molecular weights, such as beta-defensin (HBD)-1, HBD-2, and LL-37, summarized in Jacobo-Delgado et al. (2023), shows that NZ2114 shows low antimycobacterial MIC values which is important for possible future TB therapy.